Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Hematology
•
Rheumatoid Arthritis
How would you manage a patient with RA with newly diagnosed T-LGLL who was previously treated with Enbrel and is now flaring off Enbrel while on low dose methotrexate?
Related Questions
For ICI arthritis, how soon do you start DMARDs?
How do you approach management of a patient with multiple lung nodules and low titer +CCP but no active joint symptoms suggestive of RA?
How do you think about using Ropeginterferon Alfa 2B for polycythemia vera in patients with active autoimmune disease?
What is your preferred treatment for refractory warm autoimmune hemolytic anemia with autoimmune neutropenia?
How would you approach using the new vagus nerve stimulator for patients with RA?
How do you handle medication refills for patients on traditional DMARDs who are lost to follow-up?
Do you have any experience with compounded iguratimod either as adjunctive therapy or monotherapy for rheumatoid arthritis, Sjogrens, or axial spondyloarthropathy?
Would you stop methotrexate or leflunomide if MCV increases after starting the medication with no other parameters of anemia or leukopenia?
How do you approach dyspnea in a patient with seropositive rheumatoid arthritis with normal imaging findings but abnormal PFT findings (restriction, reduced DLCO)?
How would you approach managing a patient with well-controlled RA on abatacept who develops a solid malignancy?
